Skip to main content
Erschienen in: Supportive Care in Cancer 4/2019

07.11.2018 | Original Article

Factors associated with the time to first palliative care consultation in Lebanese cancer patients

verfasst von: Ziad Bakouny, Tarek Assi, Elie El Rassy, Karen Daccache, Clarisse Kattan, Aline Tohme, Marie Claire Mouhawej, Joseph Kattan

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Early palliative care is recommended for cancer patients. However, palliative care consults (PCC) are often delayed in Lebanon. The aim of this study was to identify the factors associated with timing of PCC and their impact on the place of death.

Methods

This is a retrospective, single institution, study conducted at Hotel Dieu de France University Hospital in Lebanon. The clinical and demographic characteristics of oncology patients who received PCC were obtained. Cox and logistic regression models were used to evaluate the factors determining the time to first PCC and location of death, respectively.

Results

Two hundred and ten patients were included in our analyses with a median age of 69 years (range 22–92 years). The median survival times were: overall survival 18.7 months, time to first PCC 17.9 months, and survival post-PCC 0.6 months. Among patients who were followed-up at home, the median time spent at home was 0.6 months. Late PCC were associated with a childless status (HR = 0.57, 95%CI = 0.37–0.86, p = 0.007), awareness of the diagnosis (HR = 0.64, 95%CI = 0.45–0.91, p = 0.013), and lack of palliative home care (HR = 0.42, 95%CI = 0.25–0.65, p < 0.001). Older patients (OR = 1.03, 95%CI = 1.01–1.05, p = 0.026) and those who had been followed up at home during the PCC (OR = 160.56, 95%CI = 21.39–1205.50, p < 0.001) were significantly more likely to have died at home as opposed to the hospital.

Discussion

Cancer patients often receive PCC only shortly before their death. PCC for Lebanese cancer patients were found to be significantly delayed in patients that are childless, knowledgeable of their diagnosis, and lack home palliative care.
Literatur
1.
Zurück zum Zitat Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120:1290–1314. https://doi.org/10.1002/cncr.28509 CrossRefPubMed Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120:1290–1314. https://​doi.​org/​10.​1002/​cncr.​28509 CrossRefPubMed
2.
Zurück zum Zitat Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, Fairclough D, Hanson L, Hauser J, Ko D, Lloyd L, Morrison RS, Otis-Green S, Pantilat S, Portenoy RK, Ritchie C, Rocker G, Wheeler JL, Zafar SY, Kutner JS (2010) A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med 13:1407–1413. https://doi.org/10.1089/jpm.2010.0261 CrossRefPubMedPubMedCentral Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, Fairclough D, Hanson L, Hauser J, Ko D, Lloyd L, Morrison RS, Otis-Green S, Pantilat S, Portenoy RK, Ritchie C, Rocker G, Wheeler JL, Zafar SY, Kutner JS (2010) A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med 13:1407–1413. https://​doi.​org/​10.​1089/​jpm.​2010.​0261 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Weeks JC, Cook EF, O’Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279:1709–1714CrossRefPubMed Weeks JC, Cook EF, O’Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279:1709–1714CrossRefPubMed
Metadaten
Titel
Factors associated with the time to first palliative care consultation in Lebanese cancer patients
verfasst von
Ziad Bakouny
Tarek Assi
Elie El Rassy
Karen Daccache
Clarisse Kattan
Aline Tohme
Marie Claire Mouhawej
Joseph Kattan
Publikationsdatum
07.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4543-0

Weitere Artikel der Ausgabe 4/2019

Supportive Care in Cancer 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.